Article | September 1, 2021

Addressing The Training Gap For Single-Use Technologies

By Helene Pora, Ph.D. – Vice President Technical Communication & Regulatory Strategy, Pall Corporation

Clinicians doctors meeting iStock-1264556832

Gaps in employee and contractor training remain one of the top reasons that drug manufacturers fail cGMP compliance inspections by regulatory authorities. As the adoption of single-use technology (SUT) grows, effective training can achieve rapid SUT knowledge transfer to ensure successful and reliable operation in a cGMP-compliant process.

Single-use biocontainer (bag) breakage—from shipping or handling errors—is one of the top three reasons preventing more widespread use of SUT by biopharma manufacturers. Leakage of a single-use bag was reported by BioPhorum, a global collaboration of biopharmaceutical industry leaders and subject matter experts, to range anywhere from $50,000 to more than $20 million depending on the type of bag and the material it contains.

BioPhorum noted that improved training methods could considerably decrease the occurrence of leakage. However, SUT require a different skill set than traditional stainless-steel equipment. SUT operators must be trained on the unpacking, visual inspection, installation, inflation, sterile connection, disconnection/disassembly, and disposal of contact items to avoid damage that can lead to batch failures.

This article reviews how a blended training approach of face-to-face, e-learning, virtual classrooms, virtual and mixed reality training is the best way to achieve training goals.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online